Viatris (HAM:VIA) Cash Flow for Dividends: €-479 Mil (TTM As of Mar. 2026)


HAM:VIA Viatris Inc HAM:VIA
58 GF Score
Price €14.26
GF Value €9.62
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Viatris Cash Flow for Dividends?

Viatris HAM:VIA +0.06% 58 Cash Flow for Dividends is €-479 Mil as of Mar. 2026. GuruFocus rates HAM:VIA with a GF Score™ of 58/100 and a GF Value™ of €9.62 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Viatris's cash flow for dividends for the three months ended in Mar. 2026 was €-121 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was €-479 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Viatris's quarterly payment of dividends declined from Sep. 2025 (€-119 Mil) to Dec. 2025 (€-118 Mil) but then increased from Dec. 2025 (€-118 Mil) to Mar. 2026 (€-121 Mil).

Viatris's annual payment of dividends increased from Dec. 2023 (€-528 Mil) to Dec. 2024 (€-549 Mil) but then declined from Dec. 2024 (€-549 Mil) to Dec. 2025 (€-479 Mil).

Viatris Cash Flow for Dividends Related Terms

Viatris Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Viatris's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viatris Cash Flow for Dividends Chart

Viatris Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -353.12 -549.03 -527.83 -548.93 -479.27

Viatris Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -132.55 -121.21 -119.20 -118.02 -120.75
HAM:VIA
58GF Score
Viatris Inc HAM:VIA
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viatris Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-479 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €-479 Mil mean?
Viatris (HAM:VIA) has a Cash Flow for Dividends of €-479 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Viatris and its competitors.
Is Viatris' Cash Flow for Dividends too high?
Viatris' current Cash Flow for Dividends is €-479 Mil. Overall, Viatris has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viatris' Cash Flow for Dividends compare to NBIX and UTHR?
Viatris' Cash Flow for Dividends of €-479 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Viatris and its competitors. Viatris's current Cash Flow for Dividends is €-479 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viatris stock overvalued right now?
Based on GuruFocus' analysis, Viatris (HAM:VIA) is currently considered Significantly Overvalued. The stock's GF Value™ is €9.62, compared to a current price of €14.26 — trading 48.3% above its estimated fair value. The current Cash Flow for Dividends is €-479 Mil. Viatris' overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Viatris (HAM:VIA), the current Cash Flow for Dividends is €-479 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viatris (HAM:VIA) Overvalued in 2026?

Based on GuruFocus' analysis, Viatris stock appears to be overvalued. The current stock price of €14.26 is trading 48.3% above its estimated GF Value™ of €9.62. GuruFocus considers Viatris to be Significantly Overvalued.

Key valuation signals for HAM:VIA:

  • Cash Flow for Dividends: €-479 Mil
  • GF Value™: €9.62 vs. price of €14.26 (48.3% above fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the HAM:VIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viatris Business Description

Address 1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
58GF Score

Get the complete analysis for HAM:VIA

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.26
Price
€9.62
GF Value